OneSkin
San Francisco
About OneSkin
OneSkin is a longevity company on a mission to extend the health of your skin and body. Founded by a team of four PhDs and longevity scientists, they have identified a novel proprietary peptide, OS-01, which is the first compound validated to reduce your skin's biological age by decreasing the accumulation of aged cells, improving cellular repair capacity and strengthening the epidermal skin barrier. Their flagship product, OS-01 Topical Supplement is currently available through their website.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $46.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Aug 2025)
- Website: oneskin.co
- Phone: [email protected]
Industries & Categories
Beauty, Biotechnology, Cosmetics, Health Care, Wellness
Social Profiles
Canonical: https://fsome.com/organization/oneskin-39890 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.